Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist
US8097644B2 · kind B2 · utility
9Cited by
9References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2007 |
| Grant date | Jan 17, 2012 |
| Priority date | — |
| Expiry date | Mar 23, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/5728
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds having the following general formula Iwherein: A, B, X, Y, R1, R2, R3, R4, n, o and p are as defined in the specification. Such compounds are useful for treating a disease or condition selected from the group consisting of glaucoma, dry eye, angiogenesis, cardiovascular conditions or diseases and wound healing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.